315 related articles for article (PubMed ID: 3511616)
1. Control of rejection of transplanted organs.
Keown PA; Stiller CR
Adv Intern Med; 1986; 31():17-46. PubMed ID: 3511616
[No Abstract] [Full Text] [Related]
2. Pediatric renal transplantation results are improved with triple drug therapy with cyclosporine, azathioprine, and prednisone.
MacDonell RC; Johnson K; Richie R; Nylander W; McMahon Y; Niblack G; Green W; Morrissey J; Ynares C
Transplant Proc; 1989 Feb; 21(1 Pt 2):1701-4. PubMed ID: 2652557
[No Abstract] [Full Text] [Related]
3. Triple immunosuppressive therapy in immunologic high-risk renal allograft recipients.
Cole E; Robinson C; Bear R
Transplant Proc; 1989 Feb; 21(1 Pt 2):2026-7. PubMed ID: 2652662
[No Abstract] [Full Text] [Related]
4. Effect of discontinuing or restricting cyclosporine on late renal allograft rejection and function.
Woodle ES; Heffron TG; Stuart JK; Thistlethwaite JR; Stuart FP
Transplant Proc; 1989 Feb; 21(1 Pt 2):1641-2. PubMed ID: 2652536
[No Abstract] [Full Text] [Related]
5. Effect of duration of MALG therapy in a quadruple immunosuppressive protocol.
Stratta RJ; D'Alessandro AM; Armbrust MJ; Pirsch JD; Sollinger HW; Kalayoglu M; Belzer FO
Transplant Proc; 1989 Feb; 21(1 Pt 2):1726-8. PubMed ID: 2652564
[No Abstract] [Full Text] [Related]
6. Quadruple therapy for cadaver renal transplantation.
Deierhoi MH; Sollinger HW; Kalayoglu M; Belzer FO
Transplant Proc; 1987 Feb; 19(1 Pt 3):1917-9. PubMed ID: 3274452
[No Abstract] [Full Text] [Related]
7. Aggressive needle biopsy protocol prevents loss of renal allografts to undetected rejection during early posttransplant dysfunction.
Thistlethwaite JR; Woodle ES; Mayes JT; Stuart JK; Heffron TG; Spargo BH; Stuart FP
Transplant Proc; 1989 Feb; 21(1 Pt 2):1890-2. PubMed ID: 2652614
[No Abstract] [Full Text] [Related]
8. Immunosuppression in cardiac transplantation.
Rose EA; Addonizio LJ
Bibl Cardiol; 1988; (43):1-9. PubMed ID: 3067706
[No Abstract] [Full Text] [Related]
9. Is sequential low-dose immunotherapy the preferred treatment in cadaveric renal transplantation?
Posner MP; Mendez-Picon G; King A; Nelson KP; Spicer HG; Lee HM
Transplant Proc; 1989 Feb; 21(1 Pt 2):1594-7. PubMed ID: 2652519
[No Abstract] [Full Text] [Related]
10. [Use of delayed cyclosporin A in after administration of anti-lymphocyte serum in kidney transplantation].
Hourmant M; Soulillou JP
Biomed Pharmacother; 1987; 41(5):247-9. PubMed ID: 3311191
[TBL] [Abstract][Full Text] [Related]
11. Quadruple drug therapy prevents graft loss from acute rejection without increasing mortality.
Light JA; Aquino A; Ali A; Rodriguez R; Ali S
Transplant Proc; 1987 Feb; 19(1 Pt 3):1927-30. PubMed ID: 3547897
[No Abstract] [Full Text] [Related]
12. Immunosuppressive drugs used in clinical renal transplantation.
Chatterjee SN
Urology; 1977 Jun; 9(6 Suppl):52-60. PubMed ID: 70101
[No Abstract] [Full Text] [Related]
13. An immunosuppressive protocol compatible with the United States kidney transplant diagnosis related grouping.
Stuart FP; Stuart JK; Thistlethwaite JR; Gaber AO; Mayes J
Transplant Proc; 1987 Feb; 19(1 Pt 3):1959-60. PubMed ID: 3152656
[No Abstract] [Full Text] [Related]
14. Histologic findings in acute renal allograft rejection with triple drug immunosuppressive therapy: a retrospective analysis.
Moreno RF; Pallardo LM; Garcia J; Sanchez J; Rochera A; Cabezuelo J; de Agustin PP
Transplant Proc; 1988 Oct; 20(5 Suppl 6):5-6. PubMed ID: 3051590
[No Abstract] [Full Text] [Related]
15. Cyclosporine-steroids versus conventional therapy in cadaver kidney transplantation: analysis of a randomized trial at two years.
Gianello P; Squifflet JP; Pirson Y; Stoffel M; Dereme T; Alexandre GP
Transplant Proc; 1987 Feb; 19(1 Pt 3):1867-72. PubMed ID: 3547891
[No Abstract] [Full Text] [Related]
16. Use of OKT3 in kidney, pancreas, and liver transplantation.
D'Alessandro AM; Pirsch JD; Melzer JS; Sollinger HW; Kalayoglu M; Reed A; Knechtle SJ; Belzer FO
Transplant Proc; 1990 Aug; 22(4):1748-9. PubMed ID: 2117796
[No Abstract] [Full Text] [Related]
17. Does the addition of azathioprine (Aza) to CyA monotherapy after a first rejection prevent a second rejection episode in kidney transplant patients?
Hourmant M; Taupin JL; Leymerigie F; Cantarovich D; Soulillou JP
Transplant Proc; 1989 Feb; 21(1 Pt 2):1589-90. PubMed ID: 2652517
[No Abstract] [Full Text] [Related]
18. A comparison of three immunosuppressive protocols in patients aged over 50 years.
Fryd DS; So SK; Kruse L; Canafax DM; Sutherland DE; Simmons RL; Najarian JS
Transplant Proc; 1987 Feb; 19(1 Pt 2):1530-1. PubMed ID: 3274374
[No Abstract] [Full Text] [Related]
19. Role of protocol biopsies in the treatment of refractory renal allograft rejection with FK 506.
Woodle ES; Thistlethwaite JR; Haas M; Josephson MA; Newell KA; Bruce DS; Millis JM; Piper JB; Charette JI
Transplant Proc; 1996 Apr; 28(2):998-9. PubMed ID: 8623495
[No Abstract] [Full Text] [Related]
20. [Clinical significance of immunological findings for the survival time of kidney transplants with antilymphocyte globulin therapy].
Bullinger W; Hammer C; Land W; Welter H
Chir Forum Exp Klin Forsch; 1979; ():319-24. PubMed ID: 378592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
